FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058965590> ?p ?o ?g. }

• W2058965590 endingPage "878" @default.
• W2058965590 startingPage "870" @default.
• W2058965590 abstract "The aim of the present study was to determine the impact of CYP2C19*17 on the pharmacokinetics and pharmacodynamics of the active metabolite of clopidogrel and the pharmacokinetics of proguanil. Thus, we conducted an open-label two-phase cross-over study in 31 healthy male volunteers (11 CYP2C19*1/*1, 11 CYP2C19*1/*17 and nine CYP2C19*17/*17). In Phase A, the pharmacokinetics of the derivatized active metabolite of clopidogrel (CAMD) and platelet function were determined after administration of a single oral dose of 600 mg clopidogrel (Plavix; Sanofi-Avensis, Horsholm, Denmark). In Phase B, the pharmacokinetics of proguanil and its metabolites cycloguanil and 4-chlorphenylbiguanide (4-CPB) were determined in 29 of 31 subjects after a single oral dose of 200 mg proguanil given as the combination drug Malarone (GlaxoSmithKline Pharma, Brondby, Denmark). Significant correlations were found between the area under the time–concentration curve (AUC0–∞) of CAMD and both the absolute ADP-induced P2Y12 receptor-activated platelet aggregation (r = −0.60, P = 0.0007) and the percentage inhibition of aggregation (r = 0.59, P = 0.0009). In addition, the CYP2C19*17/*17 and CYP2C19*1/*17 genotype groups had significantly higher percentage inhibition of platelet aggregation compared with the CYP2C19*1/*1 subjects (geometric mean percentage inhibition of 84%, 73% and 63%, respectively; P = 0.014). Neither the absolute ADP-induced P2Y12 receptor-activated platelet aggregation, exposure to CAMD nor the pharmacokinetic parameters of proguanil, cycloguanil and 4-CPB exhibited any significant differences among the genotype groups. In conclusion, carriers of CYP2C19*17 exhibit higher percentage inhibition of platelet aggregation, but do not have significantly lower absolute P2Y12 receptor-activated platelet aggregation or higher exposure to the active metabolite after a single oral administration of 600 mg clopidogrel." @default.
• W2058965590 created "2016-06-24" @default.
• W2058965590 creator A5005287400 @default.
• W2058965590 creator A5012651970 @default.
• W2058965590 creator A5025221854 @default.
• W2058965590 creator A5049097258 @default.
• W2058965590 creator A5053033359 @default.
• W2058965590 creator A5085680128 @default.
• W2058965590 date "2014-11-01" @default.
• W2058965590 modified "2023-09-27" @default.
• W2058965590 title "CYP2C19*17increases clopidogrel-mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrel" @default.
• W2058965590 cites W1415139109 @default.
• W2058965590 cites W1523938956 @default.
• W2058965590 cites W1666830708 @default.
• W2058965590 cites W168371622 @default.
• W2058965590 cites W1971113428 @default.
• W2058965590 cites W1972219082 @default.
• W2058965590 cites W1985338499 @default.
• W2058965590 cites W1988103863 @default.
• W2058965590 cites W1994351107 @default.
• W2058965590 cites W2000482836 @default.
• W2058965590 cites W2008000663 @default.
• W2058965590 cites W2008720907 @default.
• W2058965590 cites W2008984280 @default.
• W2058965590 cites W2011642773 @default.
• W2058965590 cites W2023372277 @default.
• W2058965590 cites W2023602049 @default.
• W2058965590 cites W2025522199 @default.
• W2058965590 cites W2028938803 @default.
• W2058965590 cites W2030975106 @default.
• W2058965590 cites W2037355442 @default.
• W2058965590 cites W2046852461 @default.
• W2058965590 cites W2047365185 @default.
• W2058965590 cites W2047390765 @default.
• W2058965590 cites W2047915768 @default.
• W2058965590 cites W2051622227 @default.
• W2058965590 cites W2053764863 @default.
• W2058965590 cites W2062118580 @default.
• W2058965590 cites W2065872061 @default.
• W2058965590 cites W2068780263 @default.
• W2058965590 cites W2068804178 @default.
• W2058965590 cites W2069096910 @default.
• W2058965590 cites W2076517423 @default.
• W2058965590 cites W2078471236 @default.
• W2058965590 cites W2081076143 @default.
• W2058965590 cites W2081558811 @default.
• W2058965590 cites W2086098797 @default.
• W2058965590 cites W2087691066 @default.
• W2058965590 cites W2091264770 @default.
• W2058965590 cites W2092267763 @default.
• W2058965590 cites W2096121276 @default.
• W2058965590 cites W2097627764 @default.
• W2058965590 cites W2100742272 @default.
• W2058965590 cites W2105523329 @default.
• W2058965590 cites W2117740737 @default.
• W2058965590 cites W2119186881 @default.
• W2058965590 cites W2121858592 @default.
• W2058965590 cites W2135575592 @default.
• W2058965590 cites W2142863079 @default.
• W2058965590 cites W2164705071 @default.
• W2058965590 cites W2166855973 @default.
• W2058965590 cites W315812671 @default.
• W2058965590 cites W48187314 @default.
• W2058965590 doi "https://doi.org/10.1111/1440-1681.12297" @default.
• W2058965590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25115434" @default.
• W2058965590 hasPublicationYear "2014" @default.
• W2058965590 type Work @default.
• W2058965590 sameAs 2058965590 @default.
• W2058965590 citedByCount "8" @default.
• W2058965590 countsByYear W20589655902015 @default.
• W2058965590 countsByYear W20589655902017 @default.
• W2058965590 countsByYear W20589655902018 @default.
• W2058965590 countsByYear W20589655902020 @default.
• W2058965590 countsByYear W20589655902021 @default.
• W2058965590 crossrefType "journal-article" @default.
• W2058965590 hasAuthorship W2058965590A5005287400 @default.
• W2058965590 hasAuthorship W2058965590A5012651970 @default.
• W2058965590 hasAuthorship W2058965590A5025221854 @default.
• W2058965590 hasAuthorship W2058965590A5049097258 @default.
• W2058965590 hasAuthorship W2058965590A5053033359 @default.
• W2058965590 hasAuthorship W2058965590A5085680128 @default.
• W2058965590 hasConcept C112705442 @default.
• W2058965590 hasConcept C126322002 @default.
• W2058965590 hasConcept C140840227 @default.
• W2058965590 hasConcept C149151106 @default.
• W2058965590 hasConcept C185592680 @default.
• W2058965590 hasConcept C203014093 @default.
• W2058965590 hasConcept C2777425658 @default.
• W2058965590 hasConcept C2777477808 @default.
• W2058965590 hasConcept C2777628954 @default.
• W2058965590 hasConcept C2777849778 @default.
• W2058965590 hasConcept C2778048844 @default.
• W2058965590 hasConcept C2778905298 @default.
• W2058965590 hasConcept C2779636613 @default.
• W2058965590 hasConcept C49059817 @default.
• W2058965590 hasConcept C526171541 @default.
• W2058965590 hasConcept C55493867 @default.
• W2058965590 hasConcept C62231903 @default.

• next